Literature DB >> 23527945

Prevalence of bipolar disorder in a HIV-infected outpatient population.

Wagner de Sousa Gurgel1, Alexandre Henrique da Silva Carneiro, Diego Barreto Rebouças, Karla Julianne Negreiros de Matos, Terezinha do Menino Jesus Silva Leitão, Fábio Gomes de Matos e Souza.   

Abstract

This study assesses the prevalence of bipolar disorder (BD) among 196 HIV-infected adult outpatients attending in a specialized unit in Fortaleza, Brazil. Patients were interviewed with the Mood Disorder Questionnaire (MDQ), the Mini International Neuropsychiatric Interview (MINI), the Alcohol Use Disorders Identification Test (AUDIT), and a socio-demographic questionnaire based on WHO's behavioral surveillance surveys. Positive MDQ screening was found in 13.2% (N=26) and the BD diagnosis was confirmed in 8.1% (N=16) of the sample. There is an almost four times higher prevalence of BD among the HIV-infected patients of the sample (8.1%) than in the general population from the USA (2.1%). The prevalence of BD type I in the HIV patients was 5.6% (N=11) which is almost six times higher than the US general population (1%). The odds ratios of sexual behaviors and substance abuse variables correlated with BD were calculated. The variables associated with the diagnoses of BD were sex with commercial partners, sex outside the primary relationship, alcohol use disorders, and illicit drug abuse. The most common psychiatric comorbidity in the BD group was substance abuse (61.5%). A better understanding of psychiatric comorbidities and behavioral aspects of HIV-positive patients may help in improving long-term outcome of these patients.

Entities:  

Mesh:

Year:  2013        PMID: 23527945     DOI: 10.1080/09540121.2013.779625

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  7 in total

Review 1.  Medical Comorbidities in Bipolar Disorder.

Authors:  Aktriti Sinha; Anam Shariq; Khaled Said; Abhinav Sharma; D Jeffrey Newport; Ihsan M Salloum
Journal:  Curr Psychiatry Rep       Date:  2018-05-07       Impact factor: 5.285

2.  Pharmacologic Treatment of Psychiatric Disorders and Time With Unsuppressed HIV Viral Load in a Clinical HIV Cohort.

Authors:  Matthew E Levy; Anne K Monroe; Michael A Horberg; Debra A Benator; Sherry Molock; Rupali K Doshi; Lindsey Powers Happ; Amanda D Castel
Journal:  J Acquir Immune Defic Syndr       Date:  2019-11-01       Impact factor: 3.731

Review 3.  HIV and Substance Use in Latin America: A Scoping Review.

Authors:  Hanalise V Huff; Paloma M Carcamo; Monica M Diaz; Jamie L Conklin; Justina Salvatierra; Rocio Aponte; Patricia J Garcia
Journal:  Int J Environ Res Public Health       Date:  2022-06-12       Impact factor: 4.614

4.  Management of Psychiatric Disorders with HIV and Dermatological Disorders.

Authors:  Om Prakash Singh; Sujit Sarkhel; Sharmila Sarkar
Journal:  Indian J Psychiatry       Date:  2022-03-23       Impact factor: 2.983

5.  Renal safety of lithium in HIV-infected patients established on tenofovir disoproxil fumarate containing antiretroviral therapy: analysis from a randomized placebo-controlled trial.

Authors:  Eric H Decloedt; Maia Lesosky; Gary Maartens; John A Joska
Journal:  AIDS Res Ther       Date:  2017-02-04       Impact factor: 2.250

6.  Bipolar spectrum disorders and associated factors among adults attending an antiretroviral therapy clinic in Gedeo zone health centers, southern Ethiopia.

Authors:  Zelalem Belayneh; Wagaye Alemu; Birhanie Mekuriaw; Zegeye Abebe
Journal:  Neuropsychiatr Dis Treat       Date:  2019-02-20       Impact factor: 2.570

7.  HIV-associated dementia presenting predominantly with clinical motor deficits: A case report.

Authors:  Laura McLean; Stephen Aradi; Roy Waknin; Brittany Rea; Marc A Camacho
Journal:  Radiol Case Rep       Date:  2022-06-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.